18 Types of High-risk Human Papillomavirus (16/18 Typing) Nucleic Acid Detection Kit (Fluorescence PCR)

A diagnostic test kit for the detection of human papillomavirus types 16 and 18 using PCR with fluorescence methodology. This kit is used to identify HPV infection status in clinical specimens.

This diagnostic kit uses real-time multiple fluorescent PCR technology combined with an Automated Fully Enclosed qPCR Instrument. It is used for in vitro qualitative detection of high-risk HPV16, HPV18, and 16 other high-risk types (HPV26, HPV31, HPV33, HPV35, HPV39, HPV45, HPV51, HPV52, HPV53, HPV56, HPV58, HPV68, HPV59, HPV66, HPV73, and HPV82) in cervical exfoliated cells or reproductive tract secretions. Test results assist in HPV auxiliary diagnosis.

Molecular detection kit for high-risk HPV types 16 and 18. Supports cervical cancer screening and risk stratification.

A molecular PCR test kit for the detection of human papillomavirus types 16 and 18. Used for cervical cancer risk assessment and screening.

PCR-based human papillomavirus detection assay capable of identifying 23 HPV genotypes including 18 high-risk and 5 low-risk variants for cervical cancer screening and auxiliary diagnosis.

Multiplex real-time PCR assay for detection and typing of human papillomavirus with specific genotyping for high-risk types 16 and 18. The kit enables rapid identification of clinically significant HPV variants.

A fully enclosed diagnostic kit with preloaded reagents for 6-plex detection of HPV types (HPV16, HPV18, and others) using cervical exfoliated cells and genital secretion samples. The kit employs magnetic beads extraction, purification, and qPCR method with results available within 2 hours and internal control monitoring throughout the process. It requires no freezer storage or transportation.

Multiplex real-time PCR kit for simultaneous detection and typing of human papillomavirus (HPV) 16 and 18 strains. Used in clinical diagnostics for cervical cancer screening and HPV genotyping. Enables rapid, multiplexed analysis from patient samples with high sensitivity and specificity.

Fluorescence PCR-based detection kit for Human Papillomavirus (HPV) identification in clinical specimens. Enables rapid, sensitive HPV genotyping for cervical cancer screening and risk stratification in diagnostic laboratories. 510(k) cleared device with fluorescence-based detection methodology.

PCR-based diagnostic kit for detection and differentiation of Human Papillomavirus types 16 and 18 in clinical samples. Designed for molecular screening and identification of high-risk HPV strains associated with cervical and other cancers. Ready-to-use format with optimized mastermix for rapid, reliable results in clinical and research laboratories.

Molecular diagnostic test for human papillomavirus detection using polymerase chain reaction technology. Enables nucleic acid-based identification of HPV pathogens for clinical screening applications.

A diagnostic kit for qualitative detection of 15 high-risk HPV E6/E7 mRNA types (16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68) in cervical exfoliated cell samples. The kit detects HPV at the viral gene transcription level, directly reflecting the expression of HR-HPV E6/E7 oncogenic genes, and is closely associated with viral integration and cellular malignant transformation. It can serve as a risk assessment tool for cervical cancer and precancerous lesions, providing accurate information for cervical cancer screening and disease prediction.